Special Interest Group 2021: Neuro-Oncology (recording) *This activity does not award CME**This activity is free of charge to those registered for ANA2021. Please click continue to access the content. Please contact us if you are prompted to pay the fee and were registered for the meeting.* Special Interest Group 2021: Education (recording) *This…

Session Title: Taking the Fight into the Tumor: Intratumoral Therapies and Novel Approaches to Blood Brain Barrier DisruptionDescription: Despite recent therapeutic advances, brain tumors remain an often fatal, and complicated-to-treat disease. Patients with the most common malignant brain tumor, Glioblastoma (GBM), rarely live more than two years despite aggressive treatment with maximal safe…

Description: This year’s Movement Disorders Special Interest Group session will focus on the non-neuronal aspects of neurodegeneration in movement disorders. While neuronal loss is the primary focus of most research in neurodegeneration, studies in these diseases demonstrate that neuron-glial interactions may have a key role in the pathogenesis of these diseases. Microglia, astrocytes and…

Description: Although stroke remains the fifth leading cause of death and the number one cause of serious long-term disability in the US, effective acute treatments (thrombolysis and thrombectomy) that reduce death and disability are available and indications keep expanding and evolving. Through case-based presentations and overview of current evidence, faculty will provide emerging applications…

Description: Arguably no medical specialty has benefited more from the last decade of genomic advances than Neurology, and the pace of discoveries continued in 2021. This session aims to keep attendees up-to-date by providing key updates from four broad facets of neurogenetic inquiry: advances in methodologies; key gene discoveries; sociological and ethical implications of genetics; and exciting…

Description: This special interest group session will focus on two areas of contemporary interest in neuromuscular disease. One session will review familial amyloid polyneuropathy and examine the recent development and release of several novel therapies that improve the natural history of this disorder. Another session will review the expanding number of recognized autoantibodies in myositis and…

Session Title: Global Neurology in the Time of COVID: Addressing Clinical Care, Research, and EducationDescription: The COVID-19 pandemic has had major global impacts on neurology care, education, and research, particularly in resource-limited settings. In this session, a diverse group of leaders in global neurology from around the world will discuss the impact of COVID-19 on delivery of…

Session Title: Equity & Quality of Neurological Care in the Virtual Care EraDescription: In this SIG we will discuss how the COVID-19 disruption of health care delivery has impacted the equity and quality of neurologic care. Speakers will cover the implications of the changes in routine inpatient and outpatient care, and subsequent significant growth of telehealth and digital health services from…

Session Title: Small Injuries with Big Impacts: Micro-structural Injury in Traumatic Brain InjuryDescription: This session will focus on micro-structural injury after traumatic brain injury (TBI). Not all injuries after TBI can be readily seen on conventional imaging techniques, prompting investigators to develop novel methods of injury detection from biomarkers to advanced imaging sequences….

Description: Multiple Sclerosis (MS) has long been considered more aggressive in people who identify as Black or African Americans, and some studies have suggested Hispanic or Latinx people with MS may also have more active disease. However, there is increasing awareness that race is a social construct, making it important to more fully identify contributors to any differences in MS outcomes, as…